Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
Clinical, Cosmetic and Investigational Dermatology Aug 10, 2017
Joe HJ, et al. – This paper conducted an appraisal of Korean patients with actinic keratosis (AK) being treated with Ingenol mebutate (IM). It also assessed the local skin reactions (LSRs) and therapeutic outcomes of low amounts of IM
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
